Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a collaboration with Cytiva, a global life sciences leader.

Continue ReadingNuclera and Cytiva collaborate to accelerate characterization of proteins for drug development

Researchers develop bioactive peptide with therapeutic and regenerative potential

Since the COVID-19 pandemic, global interest in antiviral therapies has increased significantly. Recently, with the growing attention to peptide-based drugs such as Wegovy, demand for effective peptide therapeutics derived from…

Continue ReadingResearchers develop bioactive peptide with therapeutic and regenerative potential